| Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | $ 0.00 | $ -111.64K | $ 0.00 | C$ 0.00 | C$ -18.02K |
| Operating Income | $ -3.26M | $ -3.92M | $ -6.05M | C$ -12.43M | C$ -3.68M |
| EBITDA | $ -3.14M | $ -3.80M | $ -5.91M | C$ -12.44M | C$ -2.90M |
| Net Income | $ -2.66M | $ -3.15M | $ -2.16M | C$ -10.45M | - |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 862.94K | $ 2.47M | $ 3.45M | C$ 10.43M | C$ 14.87M |
| Total Assets | $ 2.68M | $ 4.09M | $ 5.47M | C$ 12.37M | C$ 17.38M |
| Total Debt | $ 37.22K | $ 38.78K | $ 11.51K | C$ 77.60K | C$ 0.00 |
| Net Debt | $ -825.72K | $ -2.43M | $ -3.44M | C$ -10.36M | C$ -14.87M |
| Total Liabilities | $ 597.98K | $ 757.99K | $ 825.94K | C$ 5.38M | C$ 4.18M |
| Stockholders' Equity | $ 2.08M | $ 3.34M | $ 4.64M | C$ 7.00M | C$ 13.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.82M | $ -3.72M | $ -6.63M | C$ -9.01M | C$ -4.83M |
| Operating Cash Flow | $ -2.82M | $ -3.68M | $ -6.58M | C$ -8.96M | C$ -4.80M |
| Investing Cash Flow | $ -300.12K | $ -38.92K | $ -46.36K | C$ -45.70K | C$ -31.81K |
| Financing Cash Flow | $ 1.45M | $ 2.78M | $ -361.04K | C$ 3.91M | C$ 19.37M |
XORTX Therapeutics Inc (DE:ANU)
FRANKFURT:ANU
